Evidence map›Paper›PMID 32519283›Full record

ReviewCurrent osteoporosis reports2020

Bone-Muscle Mutual Interactions.

Nuria Lara-Castillo, Mark L Johnson

Abstract readReview
In one paragraph

Review in Current osteoporosis reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Low Circulating Valine Associate With High Risk of Hip Fractures.The Journal of clinical endocrinology and metabolism · 2023
    Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Nutrients · 2025
    Article
  16. Review
  17. Molecular communication from bone to skeletal muscle: an overview.Frontiers in cell and developmental biology · 2025
    Review
  18. Connecting the dots: sex, depression, and musculoskeletal health.The Journal of clinical investigation · 2024
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Nuria Lara-CastilloDepartment of Oral and Craniofacial Sciences, UMKC School of Dentistry, 650 East 25th Street, Kansas City, MO, 64108, USA.
Mark L JohnsonDepartment of Oral and Craniofacial Sciences, UMKC School of Dentistry, 650 East 25th Street, Kansas City, MO, 64108, USA. johnsonmark@umkc.edu.ORCID 0000-0002-7762-8731

Funding

Transgenic and Mechanical Loading CoreP01AG039355 · NIA · UNIVERSITY OF MISSOURI KANSAS CITY · PI BONEWALD, LYNDA F · 2012 to 2024
$19.3M
THE ROLE OF LRP5 IN BONE RESPONSE TO MECHANICAL LOADINGR01AR053949 · NIAMS · UNIVERSITY OF MISSOURI KANSAS CITY · PI JOHNSON, MARK LOUIS · 2007 to 2011
$1.6M
NIAMS NIH HHS R01 AR053949NIA NIH HHS P01 AG039355
6 · The paper itself

Abstract

purpose of reviewThe purpose of this review is to describe the current state of our thinking regarding bone-muscle interactions beyond the mechanical perspective. RECENT

findingsRecent and prior evidence has begun to dissect many of the molecular mechanisms that bone and muscle use to communicate with each other and to modify each other's function. Several signaling factors produced by muscle and bone have emerged as potential mediators of these biochemical/molecular interactions. These include muscle factors such as myostatin, Irisin, BAIBA, IL-6, and the IGF family and the bone factors FGF-23, Wnt1 and Wnt3a, PGE2, FGF9, RANKL, osteocalcin, and sclerostin. The identification of these signaling molecules and their underlying mechanisms offers the very real and exciting possibility that new pharmaceutical approaches can be developed that will permit the simultaneous treatments of diseases that often occur in combination, such as osteoporosis and sarcopenia.

Indexed as

Adaptor Proteins, Signal TransducingAminoisobutyric AcidsBone and BonesDinoprostoneFibroblast Growth Factor-23Fibroblast Growth Factor 9Fibroblast Growth FactorsFibronectinsHumansInterleukin-6Muscle, SkeletalMyostatinOsteocalcinParacrine CommunicationRANK LigandSomatomedins3-aminoisobutyric acidAdaptor Proteins, Signal TransducingAminoisobutyric AcidsDinoprostoneFGF23 protein, humanFibroblast Growth Factor-23Fibroblast Growth Factor 9Fibroblast Growth FactorsFibronectinsFNDC5 protein, humanInterleukin-6MyostatinOsteocalcinRANK LigandSomatomedinsSOST protein, humanWnt1 ProteinWnt3A ProteinBoneCrosstalkInteractionMuscleMusculoskeletal

Identifiers

PMID32519283
PMCPMC8059358

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.